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Abstract. Background: The aim of the present study was to
demonstrate the advantages of laparoscopy versus
laparotomy for treatment of extremely obese women with
early-stage endometrial cancer. Materials and Methods:
Seventy-five extremely obese patients with Body Mass Index
>35 kg/m2 and clinical stage I endometrial cancer
underwent hysterectomy and bilateral salpingo-
oophorectomy, and in all cases we performed systematic
pelvic lymphadenectomy by laparoscopy (mean BMI of
38±7.3 kg/m2) or laparotomy (mean BMI of 39±8.1 kg/m2).
Results: In two (4.4%) patients of the laparoscopy group we
observed a port site haematoma that was resolved without a
second surgery. In three patients of the laparotomy-group,
we observed dehiscence of the abdominal suture with
surgical site infection that was re-sutured. Conclusion:
Laparoscopy can be considered a safe and effective
therapeutic procedure for managing early-stage endometrial
cancer in extremely obese women with a lower complication
rate, lower surgical site infection and postoperative
hospitalization.
Several studies showed that laparoscopic treatment of
endometrial cancer offers many advantages compared to the
open-approach (1), primarily considering the less
postoperative pain, better visibility of the operative field, and
shorter hospital stay as the main benefits (2); postoperative
complications after laparoscopy seems to be reduced or
similar (3), likely related to the expertise of the operating
surgeons and the patient’s comorbidities.
The advantages of laparoscopic surgery have made it
increasingly attractive as an alternative to traditional
approaches for treatment of gynaecological malignancies,
especially endometrial cancer (3, 4). Many patients with
endometrial cancer present with comorbidity such as obesity,
hypertension, and diabetes (4). Abdominal surgery therefore
exposes patients to an increased risk of complications (5).
Vaginal hysterectomy has been demonstrated as an attractive
alternative for these patients, but this approach does not
allow for exploration of the abdominal cavity, peritoneal
washing, and lymph node dissection (6). 
Laparoscopic techniques overcome these disadvantages.
However, this procedure does not seem to modify the
incidence of recurrence or overall survival (1, 7).
The aim of the present study was to retrospectively
compare the safety, complication and recurrence rate of total
laparoscopic hysterectomy with lymphadenectomy and
laparotomic hysterectomy with lymphadenectomy for early-
stage endometrial carcinoma in a series of 75 extremely
obese women (Body Mass Index >35). 
Patients and Methods
Between November 2004 and Dicember 2013, we performed a
multicentre study of all complications after treatment of 75
consecutive extremely obese patients with clinical stage I
endometrial cancer who underwent laparoscopic (45 cases) or
laparotomic (30 cases) hysterectomy with pelvic and aortic lymph
node dissection (Table I).
For the purpose of the study, 75 patients with clinical stage I
endometrial cancer (disease limited to the uterine corpus) were
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selected. The staging of the patients was carried-out according to
the FIGO (International Federation of Gynecology and Obstetrics)
staging system (8).
All the patients who underwent laparoscopy were informed that
laparotomy would be carried-out if difficulties were encountered with
the laparoscopic approach. All women gave their informed consent.
Preoperative work-up consisted of gynaecological and rectal
examination, ultrasonographic and hysteroscopic assessment with
endometrial biopsy, chest X-ray radiograph, and Magnetic
Resonance Imaging scan to exclude suspicion of metastatic disease.
Patients with evidence of more advanced clinical stage based on
routine preoperative workup including clinical examination and
radioimaging studies, patients treated with prior pelvic
radiotherapy/chemotherapy, and patients with no available follow-
up information were excluded.
The choice between laparoscopy or laparotomy was made
preoperatively according to the surgeon’s or the patient’s preference
and was based on patient’s characteristics.
Although the surgeons involved in the current protocol were
competent in both procedures, and we considered most patients as
suitable candidates for laparoscopy or laparotomy, in our Departments,
a number of patients were specifically self-referred requesting a
laparoscopic approach for the treatment of endometrial cancer.
Exclusion criteria for the two groups were ovarian lesions,
obvious metastasis beyond the uterus, contraindications for general
anaesthesia, and systemic infections. 
Patients were not considered candidates for the laparoscopic
approach and underwent laparotomy when any of the following
criteria were present: a bulky uterus ≥12-week size or where vaginal
removal of the uterus would require morcellation; documented
significant cardiopulmonary disease defined as a history of cardiac
failure, myocardial infarction, unstable angina, or poorly-controlled
pulmonary obstructive disease, or contraindicating prolonged
Trendelenburg position. Prior abdominal surgery was not considered
a contraindication for the laparoscopic approach.
According to the FIGO staging system, all patients underwent
surgical staging consisting of inspection of the intraperitoneal
cavity, peritoneal washing, total hysterectomy, are bilateral salpingo-
oophorectomy; in all cases we performed systematic bilateral pelvic
lymphadenectomy. 
Para-aortic lymphadenectomy with the superior border of the
dissection being the inferior mesenteric artery would be performed
in all cases with positive pelvic lymph nodes discovered at frozen-
section evaluation, in patients with poorly-differentiated tumours
with myometrial invasion greater than 50% (stage IB).
Vaginal cuff brachytherapy alone was prescribed for patients with
FIGO stage IA G2 or G3. Adjuvant whole-pelvic radiation was
recommended for patients with surgical stage IB and II in
combination with vaginal cuff brachytherapy. Chemotherapy was
offered only to patients with FIGO stage III-IV disease in
combination, in some cases, with radiotherapy.
The patients’ characteristics reported were age, weight, BMI,
stage, histological type, tumour grade, operative time, estimated
blood loss, perioperative blood transfusions, number and status of
lymph nodes obtained, myometrial invasion, length of hospital stay,
time to resumption of normal bladder function, intraoperative and
postoperative complications, overall survival and disease-free
survival. 
The technique utilized for laparoscopic hysterectomy with
lymphadenectomy has been described in a previous report (5), while
in the abdominal (laparoscopic) hysterectomy, abdominal access
was obtained through a vertical midline skin incision and the
hysterectomy consisted of an extrafascial total hysterectomy. Both
fallopian tubes were coagulated before the insertion of the uterine
manipulator in the LPS group.
Information regarding patients was obtained from the hospital
records and direct reports from the patients. We confirmed
information and status on patients by direct telephone interviews. 
Follow-up visits were scheduled monthly for the first three
months, then every three months for the first two years, every six
months for three years, and yearly thereafter. The mean duration of
follow-up was 48.5 months (range=3-97 months).
Statistical analysis. Fisher’s exact test and the χ2 test were used for
statistical analysis. Variables with normal distribution are expressed
as mean and 95% Confidence Interval±standard deviation.
Nonparametric variables are expressed as the median and range. 
Disease-free survival (DFS) was defined as the period from
surgery until the date of first recurrence. Overall survival (OS) was
calculated from the date of surgery to the date of death. Data on
living patients were collected at the last follow-up visit.
Statistical analysis was performed using the Statistical Package
for Social Science for Windows (SPSS, Inc., Chicago, IL, USA). A
p-value less than 0.05 was considered statistically significant. 
Results
Table I lists the characteristics of women with endometrial
carcinoma on the basis of the surgical approach used and the
complications experienced, while Table II shows the
intraoperative data for each group.
There were no significant differences regarding mean age,
mean weight, mean BMI, parity, comorbidities, surgical
staging, surgical stage, grade and post-operative treatment.
Two cases of moderate subcutaneous emphysema occurred
at the time of pneumoperitoneum creation managed by
waiting 10 min before continuing the operation. 
In three patients of the laparotomy-group, we observed a
dehiscence of the abdominal suture with surgical site
infection in the first week after surgery; these were re-
sutured with interrupted sutures with no sequelae.
Postoperative fever was reported in 6 (20%) patients of the
laparotomy group and in 2 patients of the laparoscopy
(4.4%) group (p<0.01).
No case of port-site metastasis, no vascular injury and no
wound complications were detected.
In all cases, the laparoscopic procedures were successfully
completed without conversion to laparotomy (Figure 1) and
no patient of either group required an intraoperative or
postoperative blood transfusion. The catheter was removed
one day after the surgical procedure.
In two (4.4%) patients of the laparoscopy group, we
observed a port site haematoma, diagnosed in the first 24 h
after surgery as a net haemoglobin decline, which resolved
spontaneously without a second surgery.
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One case of bladder injury occurred in the laparoscopy
group at the time of utero-vesical fold incision that was
laparoscopically sutured. 
In one patient of the laparoscopy group, we observed a
postoperative haematoma that was diagnosed in the first 24 h
after surgery as a net haemoglobin decline; this was resolved
with haemostasis performed with bipolar forceps by
laparoscopy after the cavity was adequately drained, without
conversion to laparotomy. 
Two weeks after surgical procedure, we observed
lymphorrhea at pelvic examination as profuse discharge of
lymphatic fluid that was leaking from the cuff in 5 (11.1%)
patients in the laparoscopy-group and in 3 (10%) in the
laparotomy-group (p=0.08). In all cases, this condition
resolved spontaneously after 30-45 days. 
One case of pelvic lymphocyst was reported; it should be
noted that there was no routine postoperative radiological
assessment to determine the incidence of lymphocysts in this
series. Imaging evaluation was performed only in
symptomatic patients. 
Although postoperative fever was reported in 6 (20%)
patients of the laparotomy group and in 2 patients (4.4%) of
the laparoscopy group (p<0.01), there was no statistical
difference in the rate of other complications in either group. 
No patients of the either group had positive pelvic lymph
nodes discovered at frozen section evaluation.
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Table I. Intraoperative data.
Intraoperative data Laparoscopy Laparotomy p-Value
(N 45) (N 30)
Blood loss (ml; mean±Standard deviation) (95% CI) 65±15, 22-95 125±32, 50-270 <0.01
Median haemoglobin decline (g/dl) 0.8 range 0.2-2.4 1.6 range 0.3-2.9 <0.01
Operative time (min; mean±SD) (95% CI) 166±21, 116-208 143±25, 117-197 0.08
Dehiscence of the suture 0 3 (10%) <0.01
Postoperative fever (%) 2 (4.4%) 6 (20%) <0.01
Port-site haematoma 2 (4.4%) 0 <0.01
Bladder injury 1 (2%) 0 0.07
Hospital stay (days; mean±SD) (95% CI) 3.1±0.4 range 2-9 6.3±1.1 range 2-10 <0.01
Postoperative haematoma 1 (2%) 0 0.07
Recurrence (no.) (%) 4 (8.8%) 2 (6.6 %) 0.08
Time of postoperative ileus (h; mean±SD) (95% CI) 21±5, range 8-39 33±8, range 11-41 <0.01
CI=Confidence interval; SD=standard deviation.
Table II. Patients’ characteristics
Patients Laparoscopy Laparotomy p-Value
(N 45) (N 30)
Age (years; mean±SD) (95% CI) 60±11 39-81 63±14 43-84 0.075
Mean BMI (kg/m2; mean±SD) (95% CI) 38±7.3 35-64 39±8.1 35-56 0.06
Grading (no.)
I 14 (30%) 10 (33%) 0.081
II 23 (51%) 14 (46%) 0.075
III 8 (19%) 6 (22%) 0.061
Stage (no.)
IA 14 (32%) 8 (28%) 0.067
IB 24 (54 %) 17 (56%) 0.073
II 3 (6%) 2 (6%) 0.061
IIIA 0 1 (5%) 0.07
IIIB 0 0 N.S.
IIIC 4 (8%) 2 (6%) 0.08
Pelvic lymph nodes (no; mean ± SD) (95% CI) 23.5±5.8 16-39 19.2±5.4 17-38 0.073
CI=Confidence interval; SD=standard deviation; BMI: body-mass index.
One patient in the laparoscopy group and two in the
laparotomy group had positive pelvic lymph nodes (Figure
2) discovered at final histological examination.
Thirty-nine out of 75 (53%) patients received adjuvant
treatment: 16 (22%) underwent brachytherapy-only; 20
(26%) had combined brachytherapy and radiotherapy and 3
(5%) had chemotherapy combined with radiotherapy. There
was no significant difference between the two groups with
respect to adjuvant treatment.
After a median follow-up of 15.5 (range=1-28) months,
the total recurrence rate of the entire population was 8%
(N=6): 9 out of 45 (8.8%) patients of the laparoscopy group
had a recurrence (two vaginal recurrences, one intestinal
recurrence, one liver recurrence); two out of 30 (6.6%)
patients of the laparotomy group had a recurrence. 
Disease free-survival shows no significant difference
between the two groups (log-rank test, p=0.08): 88.1% of the
patients are free of disease in the laparoscopy group versus
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Figure 1. Laparoscopic procedures were successfully completed without
conversion to laparotomy and no patient required an intraoperative or
postoperative blood transfusion.
Figure 2. The obturator fossa is entered laterally and the obturator
nerve and vessels are skeletonized, before removing superficial and deep
obturator lymph nodes.
Figure 3. No significant difference was found between the two groups
when disease-free survival rate was compared. LPS: Laparoscopy; LPT:
laparotomy.
Figure 4. Dissection of the medial pararectal space by introducing
endoshears and bipolar forceps into the areolar tissue medially to the
ureter. 
93.4% in the laparotomy group. No significant difference
was found between the two groups when the recurrence rate
was compared (p=0.08) (Figure 3). 
Discussion
Many patients with endometrial cancer present with
comorbidity such as obesity, hypertension, and diabetes.
Abdominal surgery, therefore, exposes patients to increased
risk of complications (9).
The role of minimally-invasive surgical staging in the
management of extremely obese patients with apparent early
endometrial cancer continues to evolve. Recently, several
studies concluded, as others, that the postoperative
complications after laparoscopic treatment are reduced or
similar (5, 9-12).
Malzoni et al., in a prospective randomized study on 159
women with stage I endometrial cancer, compared the
feasibility, safety and morbidity of laparoscopic with that of
laparotomic hysterectomy with lymphadenectomy for early-
stage endometrial cancer. They concluded that laparoscopy
is a suitable procedure for the treatment of patients with
early endometrial cancer without compromising the degree
of oncological radicality required (5).
In a recent study, Lu et al. compared laparoscopic
approach with the conventional laparotomic approach for the
treatment of 272 patients with endometrial carcinoma in a
prospective randomized trial. They concluded that
laparoscopic surgery is a safe and reliable alternative to
laparotomy in the management of endometrial carcinoma,
with significantly reduced hospital stay and postoperative
complications; however, it does not seem to improve the
overall survival or the 5-year survival rate (11).
The Gynecologic Oncology Group LAP2 trial compared
laparoscopy and laparotomy for comprehensive surgical
staging of patients with stage I to IIA uterine cancer that
were randomly assigned to laparoscopy (N=1,696) or
laparotomy (N=920). Laparoscopy led to fewer moderate to
severe postoperative adverse events than did laparotomy
(14% vs. 21%, respectively; p<0.0001) but similar rates of
intraoperative complications, despite having a significantly
longer operative time (median, 204 vs. 130 min, respectively;
p<0.001). Laparoscopic surgical staging for uterine cancer
is feasible and safe in terms of short-term outcomes and
results in fewer complications (12).
In this multicentre study, no significant difference in
intraoperative complications was observed between groups,
whereas postoperative complications were significantly less
common in the laparoscopy than in the laparotomy group.
Our study confirms that laparoscopy in extremely obese
women is associated with safety and efficacy outcomes that
are similar to those that have been reported for laparotomy
for the treatment of endometrial cancer (13, 14). In fact, in
all cases, the laparoscopy procedures were successfully
completed without conversion to laparotomy and no patient
required an intraoperative or postoperative blood transfusion.
No case of port-site metastasis, no vascular injury and no
wound complications were detected; no significant difference
was found between the two groups when the recurrence rate
was compared. Moreover, the laparoscopy permits better
exposure of the operative field in association with the
advancement of laparoscopic techniques, allowing better
dissection of the pelvic spaces (Figure 4); however, it should
be noted that laparoscopic procedures were always
performed by the same surgical team (4, 7, 12). Therefore,
it appears from the data of our study that laparoscopy may
offer significant advantages over laparotomy in the
comprehensive surgical management of extremely obese
women with endometrial cancer, but it should be performed
by an advanced laparoscopic gynaecologic oncologist.
Complete laparoscopic surgical staging is more difficult
in the morbidly obese, and other patient factors, such as
associated comorbidities, adhesive disease, large uterus,
fatty mesentery and inability to tolerate steep Trendelemburg
positioning, have limited widespread use of this approach in
endometrial carcinoma (15). Obese patients with associated
co-morbidities had the most to gain from a successfully
completed minimally invasive procedure, but also offered
the surgeon the greatest challenges in completing the
surgery (16). 
Our study confirms that the laparoscopic approach remains,
in expert hands, the procedure better-related to the best short-
term outcomes (13-19). In our study, laparoscopy was
associated with a shorter duration of postoperative ileus, fewer
cases of dehiscence of the suture with surgical site infection,
reduced cases of postoperative fever, and reduced time of
discharge when compared to laparotomy. The follow-up
suggested that laparoscopic and laparotomic treatment of
endometrial cancer have the same therapeutic efficacy. 
Conclusion 
Our data confirm that the use of minimally-invasive
techniques in extremely obese women does not have an
adverse impact on survival, and improves quality of life in
the postoperative period, with reduced time-to-discharge.
The low rate of intraoperative and postoperative
complications observed in the laparoscopy group highlights
the feasibility, safety and efficacy of this surgical approach
for these extremely obese patients. Further studies and
cost–benefit analyses are required to determine if the use of
laparoscopy improves outcomes over standard laparotomy,
and if the advantages of this technique could be extended to
a larger proportion of patients, although multicentre
randomized trials and long-term follow-up are required to
evaluate the overall oncological outcomes of this procedure.
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